At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
Active Transcutaneous Magnetic Stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving Functions in Veterans With Post-Traumatic Peripheral Neuropathic Pain
In Brief
A clinical study evaluating Active Transcutaneous Magnetic Stimulation and Sham Transcutaneous Magnetic Stimulation for Neuropathic Pain. Completed, enrolled 57 participants across 1 site.
Detailed Summary
The proposed study will set the foundation for future multi-center studies. To validate tMS as a non-contact and non-invasive pain treatment option for reducing pain in Veterans with PTP-NP and improving their overall functions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuropathic Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartNov 2016
First PostedDec 2016
Primary CompletionSep 2019
TodayJul 2026
First PostedDec 2, 2016
Enrollment StartNov 1, 2016
Primary CompletionSep 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 9.6 years ago
Interventions
Active Transcutaneous Magnetic Stimulationdevice
Active transcutaneous magnetic stimulation (TMS) at the target site of nerve damage/injury.
Sham Transcutaneous Magnetic Stimulationdevice
Sham TMS will consist of the same parameters as active, however, the subject will be shielded from the magnetic field of the coil.